CN108289478A - Include the feed addictive for aquatic animal of essential oil and lysozyme - Google Patents
Include the feed addictive for aquatic animal of essential oil and lysozyme Download PDFInfo
- Publication number
- CN108289478A CN108289478A CN201680058693.7A CN201680058693A CN108289478A CN 108289478 A CN108289478 A CN 108289478A CN 201680058693 A CN201680058693 A CN 201680058693A CN 108289478 A CN108289478 A CN 108289478A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- purposes
- fish
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000010335 lysozyme Nutrition 0.000 title claims abstract description 92
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title claims abstract description 87
- 108010014251 Muramidase Proteins 0.000 title claims abstract description 85
- 241001465754 Metazoa Species 0.000 title claims abstract description 57
- 239000004325 lysozyme Substances 0.000 title claims abstract description 57
- 229960000274 lysozyme Drugs 0.000 title claims abstract description 57
- 102000016943 Muramidase Human genes 0.000 title claims abstract description 39
- 239000000341 volatile oil Substances 0.000 title description 22
- 235000019688 fish Nutrition 0.000 claims abstract description 64
- 241000251468 Actinopterygii Species 0.000 claims abstract description 62
- 230000000694 effects Effects 0.000 claims abstract description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 43
- PXIKRTCSSLJURC-UHFFFAOYSA-N Dihydroeugenol Chemical compound CCCC1=CC=C(O)C(OC)=C1 PXIKRTCSSLJURC-UHFFFAOYSA-N 0.000 claims abstract description 42
- 150000001875 compounds Chemical class 0.000 claims abstract description 42
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229920001184 polypeptide Polymers 0.000 claims abstract description 33
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 33
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims abstract description 29
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims abstract description 29
- 235000013985 cinnamic acid Nutrition 0.000 claims abstract description 29
- 229930016911 cinnamic acid Natural products 0.000 claims abstract description 29
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims abstract description 29
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229940100630 metacresol Drugs 0.000 claims abstract description 21
- 244000005700 microbiome Species 0.000 claims abstract description 18
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000005770 Eugenol Substances 0.000 claims abstract description 16
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960002217 eugenol Drugs 0.000 claims abstract description 16
- 241000972773 Aulopiformes Species 0.000 claims abstract description 12
- 235000019515 salmon Nutrition 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 241000269799 Perca fluviatilis Species 0.000 claims abstract description 8
- 244000000010 microbial pathogen Species 0.000 claims abstract description 7
- 241001519451 Abramis brama Species 0.000 claims abstract description 5
- 241000252233 Cyprinus carpio Species 0.000 claims abstract description 5
- 241000276701 Oreochromis mossambicus Species 0.000 claims abstract description 5
- 241001233037 catfish Species 0.000 claims abstract description 5
- 150000001413 amino acids Chemical class 0.000 claims description 72
- 239000000203 mixture Substances 0.000 claims description 54
- 229940051921 muramidase Drugs 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 claims description 11
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 claims description 11
- 229940088601 alpha-terpineol Drugs 0.000 claims description 11
- 230000034994 death Effects 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 238000012217 deletion Methods 0.000 claims description 9
- 230000037430 deletion Effects 0.000 claims description 9
- 241000233866 Fungi Species 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 241001326562 Pezizomycotina Species 0.000 claims description 4
- 241000277331 Salmonidae Species 0.000 claims description 2
- 241000235349 Ascomycota Species 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 20
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 235000001014 amino acid Nutrition 0.000 description 57
- 229940024606 amino acid Drugs 0.000 description 52
- 102100033468 Lysozyme C Human genes 0.000 description 47
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 235000019733 Fish meal Nutrition 0.000 description 24
- 239000004467 fishmeal Substances 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 23
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- 230000000845 anti-microbial effect Effects 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 239000000843 powder Substances 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000008188 pellet Substances 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 239000004375 Dextrin Substances 0.000 description 9
- 229920001353 Dextrin Polymers 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 235000019425 dextrin Nutrition 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 125000000539 amino acid group Chemical group 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 description 7
- 239000008158 vegetable oil Substances 0.000 description 7
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 6
- 241000194040 Lactococcus garvieae Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000021323 fish oil Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 6
- 239000004299 sodium benzoate Substances 0.000 description 6
- 235000010234 sodium benzoate Nutrition 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 5
- 108010011619 6-Phytase Proteins 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- 241000238557 Decapoda Species 0.000 description 5
- -1 Direct-fed Object Chemical class 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 241000277263 Salmo Species 0.000 description 5
- 241000194056 Streptococcus iniae Species 0.000 description 5
- 238000009360 aquaculture Methods 0.000 description 5
- 244000144974 aquaculture Species 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000010216 calcium carbonate Nutrition 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229940085127 phytase Drugs 0.000 description 5
- 239000004302 potassium sorbate Substances 0.000 description 5
- 235000010241 potassium sorbate Nutrition 0.000 description 5
- 229940069338 potassium sorbate Drugs 0.000 description 5
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 5
- 229910052939 potassium sulfate Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000007771 core particle Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003746 feather Anatomy 0.000 description 4
- 208000010824 fish disease Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 235000011151 potassium sulphates Nutrition 0.000 description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 241000932614 Acremonium alcalophilum Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 102100037611 Lysophospholipase Human genes 0.000 description 3
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- 206010047400 Vibrio infections Diseases 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000021312 gluten Nutrition 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005996 Blood meal Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 241000276435 Gadus Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001600139 Moritella viscosa Species 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- MNLRQHMNZILYPY-MKFCKLDKSA-N N-acetyl-D-muramic acid Chemical class OC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O MNLRQHMNZILYPY-MKFCKLDKSA-N 0.000 description 2
- 108090000553 Phospholipase D Proteins 0.000 description 2
- 241000259813 Trichophaea saccata Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 241001148129 Yersinia ruckeri Species 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 239000004301 calcium benzoate Substances 0.000 description 2
- 235000010237 calcium benzoate Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 2
- 239000004303 calcium sorbate Substances 0.000 description 2
- 235000010244 calcium sorbate Nutrition 0.000 description 2
- 235000011132 calcium sulphate Nutrition 0.000 description 2
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000004300 potassium benzoate Substances 0.000 description 2
- 235000010235 potassium benzoate Nutrition 0.000 description 2
- 229940103091 potassium benzoate Drugs 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 239000010822 slaughterhouse waste Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- JDLYKQWJXAQNNS-UHFFFAOYSA-L zinc;dibenzoate Chemical compound [Zn+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 JDLYKQWJXAQNNS-UHFFFAOYSA-L 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000607525 Aeromonas salmonicida Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000122170 Aliivibrio salmonicida Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000626614 Chalaropsis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001635206 Conger conger Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101710089042 Demethyl-4-deoxygadusol synthase Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 1
- 241001596774 Epinephelus akaara Species 0.000 description 1
- 241001656472 Epinephelus morio Species 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 108020002496 Lysophospholipase Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000202240 Morone americana Species 0.000 description 1
- 241001481825 Morone saxatilis Species 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108700022034 Opsonin Proteins Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 102100032967 Phospholipase D1 Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 241001517016 Photobacterium damselae Species 0.000 description 1
- 241001517024 Photobacterium damselae subsp. piscicida Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000192126 Piscirickettsia salmonis Species 0.000 description 1
- 208000037113 Piscirickettsiaceae Infections Diseases 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000277289 Salmo salar Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000736131 Sphingomonas Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000883295 Symphyla Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 241000607618 Vibrio harveyi Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- ONIOAEVPMYCHKX-UHFFFAOYSA-N carbonic acid;zinc Chemical compound [Zn].OC(O)=O ONIOAEVPMYCHKX-UHFFFAOYSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 150000001896 cresols Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000007701 flash-distillation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N glucosamine group Chemical group OC1[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960004109 potassium acetate Drugs 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229950010257 terpin Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- RBNWAMSGVWEHFP-UHFFFAOYSA-N trans-p-Menthane-1,8-diol Chemical compound CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 238000007817 turbidimetric assay Methods 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 244000000028 waterborne pathogen Species 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Husbandry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Insects & Arthropods (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to the combinations of natural active matter and the polypeptide with lysozyme activity selected from α firpenes, α terpineols, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene to be used for aquatic animal in manufacture, in particular for the purposes in cold water fish (such as salmon, bream, perch) and the fodder compound of warm water fish (such as carp, Tilapia mossambica, catfish).More particularly it relates to which substance is used to improve the feed conversion rate and/or daily gain, the microorganism species for adjusting enteron aisle and for protecting animal from the purposes that is infected caused by pathogenic microorganisms (especially gram-positive microorganism) of fish as defined above.
Description
The present invention relates to the combinations of natural essential oil active matter and at least one polypeptide with lysozyme activity to use in manufacture
In aquatic animal (including fish and shrimp), in particular for cold water fish (such as salmon, bream, perch) and warm water fish (such as
Carp, Tilapia mossambica, catfish) feed in purposes.
Sequence table explanation
The application includes the sequence table of computer-reader form, is incorporated herein by reference.
SEQ ID NO:1 is as described in WO2013/076253 from the wild of Acremonium alcalophilum
The mature amino acid sequence of type GH25 lysozymes.
SEQ ID NO:2 be the gene order from the Tri-chophaea saccata GH24 lysozymes detached.
SEQ ID NO:3 be from SEQ ID NO:2 amino acid sequences derived.
SEQ ID NO:4 be the mature amino acid sequence of the wild type GH24 lysozymes from Trichophaea saccata
Row.
SEQ ID NO:5 be the maturation of the wild type GH22 lysozymes (hen egg-white lysozyme) from Gallus gallus
Amino acid sequence.
SEQ ID NO:6 be primers F -80470.
SEQ ID NO:7 be primer R-80470.
SEQ ID NO:8 be primer 8643.
SEQ ID NO:9 be primer 8654.
Introduction
The present invention relates to selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinol
The natural essential oil active matter of alkene manufacture be used for aquatic animal (including fish and shrimp), in particular for cold water fish (such as salmon,
Bream, perch) and the feed of warm water fish (such as carp, Tilapia mossambica, catfish) in purposes.
More particularly it relates at least one, preferably at least two kinds essential oil active matters as defined above and tool
There are feed conversion rate and/or daily gain of the combination of the polypeptide of lysozyme activity for improving fish, for by adjusting enteron aisle
Microorganism species and/or by protecting animal to reduce the purposes of the death rate from being infected caused by pathogenic microorganisms.
Lysozyme is a kind of by many biological as the O- glycosyl hydrolases generated to antibacterial defensive mechanism.It should
Enzyme causes the hydrolysis of bacteria cell wall by cutting the glycosidic bond of peptide glycan;The peptide glycan is a kind of important knot in bacterium
Structure molecule.After the cell wall of bacterium dies down because of bacteriolyze enzyme effect, bacterial cell is cracked due to osmotic pressure.
Lysozyme is present in many biologies, such as virus, plant, insect, birds, reptile and mammal.It is feeding
In newborn animal, lysozyme has been isolated from nasal discharge, saliva, tears, enteron aisle, urine and breast.Cleavage N- acetyl
Glycosidic bond between No. 1 carbon of base muramic acid and No. 4 carbon of N- acetyl group-d-glucosamine.In vivo, both sugar polymerizations are formed
Cell wall polysaccharides.
Lysozyme has been classified as five kinds of different glycoside hydrolase (GH) families (CAZy, www.cazy.org):Ovum gallinaceum
Clear lysozyme (GH22), goose hen egg white lysozyme (GH23), bacteriophage T4 Lysozyme (GH24), Sphingomonas flagellum egg whites
(GH73) and Chalaropsis lysozymes (GH25).Lysozyme from GH23 and GH24 families initially knows from bacteriophage, most
Closely just identified in fungi.It has been found that bacteriolyze enzyme family GH25 and other bacteriolyze enzyme families are structurally independent.
Hen egg-white lysozyme is obtainable major product on commercial market, but it does not cut such as Staphylococcus
N in aureus cell walls, 6-O- diacetyl muramic acid, therefore cannot especially crack this important human pathogen
(Masschalck B,Deckers D,Michiels CW(2002),“Lytic and nonlytic mechanism of
inactivation of gram-positive bacteria by lysozyme under atmospheric and high
hydrostatic pressure”,J Food Prot.65(12):1916-23)。
In addition, the present invention relates to a kind of novel fish feed composition, it includes it is at least one, preferably at least two kinds or three
Kind selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene reactive compound with
The combination of at least one antimicrobial polypeptide with lysozyme activity is as active constituent.
A key factor in aquaculture is turnover rate.Turnover rate by fish how soon can grow into trappable size Lai
It determines.For example, by atlantic salmon (Atlantic salmon) from samlet (when atlantic salmon can be turned for the first time from fresh water
Physiological stage when moving on to seawater) raising needs 12-18 a month to trappable size.Fast turnover has several positive effects
Fruit.First, it contributes to cash flow.Secondly, it improves risk management.Particularly, high mortality is weight for the person of breeding fish
Big risk.
It is well known that unbalance microorganism species and/or the infection caused by pathogenic microorganisms can cause the death rate to improve.
Fish disease is common, and the possibility broken out within long growth period is higher.There is also fishes due to (such as when draping
) unexpected or due to bad weather causes fish column broken and escapes risk.
For other farm-animals, prevent disease to develop to be well known using antibiotic and vaccine.It is supported in aquatic products
In growing, the use of antibiotic less extensively-at least in cold aqueous aquaculture so-this is because in fact transmission
Must be very fast, the fish of illness eats seldom, and due also to negative effect of the drug containing feed discarded to environment.Vaccine is available
When be widely used, but they are developed for all diseases.
As the substitute of synthetic drug, the purposes of plant extracts and essential oil in animal feed is described in document.
For example, patent WO2011/006993 describes purposes of the essential oil in fish meal.It is kept away however, WO2011/006993 is not recorded
Exempt to infect caused by gram-positive microorganism.In addition, in example disclosed above, only there is limited work(using essential oil
Effect.
Therefore, there is still a need for (include for the anti-of gram-positive microorganism by any preventive means in aquaculture
Microbial activity) develop to prevent disease, to reduce the death rate.
Present inventor it was unexpectedly found that:The combination of substance as defined above has in fish meal
Great potential, for example, for improving feed conversion rate (FCR) and/or weightening and/or for adjusting intestinal flora.In addition, invention
People it was unexpectedly found that:Novel fish feed composition also has the antimicrobial acivity for gram-positive microorganism,
It is reduced so as to cause the death rate.Unique selection of the reactive compound of the present invention allows control to be drawn by many different pathogens for the first time
The many fish diseases risen.
Therefore, in the first specific implementation mode, the present invention relates at least one, preferably at least two are used in fish meal
Kind selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene reactive compound with
The combination of microbic muramidase come improve feed conversion rate (FCR) and/or weightening and/or (by adjust intestinal microflora
And/or by preventing the disease caused by pathogenic microorganisms, preferably caused by gram-positive microorganism) reduce the death rate
Method.
For example, having shown that:The present invention selected compounds (such as:The group of cinnamic acid and australene and bacterium lysozyme
Close) it is shown in terms of the growth for inhibiting Lactococcus garvieae (a kind of disease especially found in cold water fish)
Go out excellent effect.Combination according to the present invention also exhibits confrontation Streptococcus iniae, and (one kind is especially in warm water
The disease found in property fish) excellent effect.
In alternative embodiment, australene and/or α-terpineol and/or cinnamic acid and/or dihydroeugenol and/or
Eugenol and/or metacresol and/or terpinolene are applied in combination at least one antimicrobial polypeptide with lysozyme activity, with
Improve animal feed digestibility and/or maintains animal health by supporting function of immune system.
In another embodiment, the present invention relates to use at least three kinds to be selected from australene, α-terpin in fish meal
Alcohol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene reactive compound there is lysozyme at least one
The combination of active antimicrobial polypeptide come improve feed conversion rate (FCR) and/or weightening and/or (by adjust enteric microorganism
Flora and/or pass through prevent the disease caused by pathogenic microorganisms) reduce the death rate method.
In one preferred embodiment, australene and cinnamic acid are applied in combination with bacterium lysozyme to improve animal feeding
Expect digestibility and/or maintains animal health by supporting function of immune system.
Definition
Term feed or fodder compound refer to any compound for being suitable for or being intended to be taken in by animal, product, mixing
Object or composition.
FCR can be measured based on fish growth experiment, and the experiment includes the first processing, wherein by least two bases
The mixture of the compound of the present invention is added to every suitable concentration of kg feeds in animal feed;With second processing (control),
The compound is not added into animal feed.
As is generally known, improved FCR is less than control FCR.In a particular embodiment, compared with the control, FCR improves
(reduce) at least 1.0%, preferably at least 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2.0%, 2.1%, 2.2%,
2.3%, 2.4% or at least 2.5%.
Term as used herein " enteron aisle " indicates gastrointestinal tract or alimentary canal (also referred to as digest tube), refers to that many cells are dynamic
Dietary intake, digestion food are to extract energy and nutrients and the tract of residual waste is discharged in object.
Term as used herein enteron aisle " microorganism species " refer to be present in enteron aisle and by help appropriate digestion come
The natural microbial culture kept fit.
Term " adjusting " related with intestinal microflora used herein generally means that normal in health and function
Animal in change, manipulate, its function of variations or modifications or state, i.e. non-therapeutic use.
Term as used herein " supporting function of immune system " refers to being made by the immunostimulation that the compound obtains
With.
Term as used herein " death rate " refer to growth phase at the end of surviving animals and pond in include initially
Animal quantity ratio.It can be measured based on fish challenge trial (fish challenge trail), the fish attack
Experiment is comprising by two groups of fishes of specific fish disease pathogen attack, it is therefore an objective to cause the death rate of the animal 40-80% in untreated fish group.
However, in the attack group for the mixture for feeding at least two compound according to the present invention per Kg feed suitable concentrations, with
Untreated fish group is compared, and the death rate reduces at least 5%, preferably at least 10%, 15%, 20%, 25%, 30%, 35%, 40%,
45% or at least 50%.
Animal feed:Term " animal feed " refer to any compound for being suitable for or being intended to be taken in by animal, product or
Mixture.Animal feed for nonruminant generally comprises concentrate and the micro- life of vitamin, minerals, enzyme, Direct-fed
Object, amino acid and/or other feed ingredients (such as in pre-composition), and the animal feed for being used for ruminant generally comprises grass
Expect (including roughage and ensilage), and concentrate and vitamin can be further included, minerals, enzyme, directly raised
Feed microorganism, amino acid and/or other feed ingredients (such as in pre-composition).
Antimicrobial acivity:Term " antimicrobial acivity " is defined herein as killing microorganism (such as algae, Gu
Bacterium, bacterium, fungi and/or protozoan) or inhibit growth activity.For example, antimicrobial acivity can be bactericidal
(mean kill bacterium) or inhibit (the meaning to prevent bacterial growth) of bacterium.Antimicrobial acivity may include that being catalyzed peptide gathers
It is residual with N- acetyl group-d-glucosamine in chitosan between N- acetylmuramic acids and N- acetyl group-d-glucosamine residue in sugar
The hydrolysis of 1,4- β-key between base.Antimicrobial acivity can also be combined with the surface of microorganism including lysozyme and inhibit it
Growth.Anti-microbial effect can also include using the lysozyme of the present invention, by inhibiting or reducing bacteriotoxin and pass through tune
Reason plain (opsonin) acts on to activate bacterial autolysin, as immunostimulant.
For the purposes of the present invention, the (" survey of antimicrobial acivity of the anti-microbial test described in embodiment 6
It is fixed ") measure antimicrobial acivity.Antimicrobial acivity is determined by the diameter of clear area (clearing zone), if used
Clear area is more than 2mm when 50%Mueller-Hinton culture mediums (pH 6), then antimicrobial acivity is assessed as significantly.
Concentrate:Term " concentrate " means there is high protein and the feed of energy concentration, for example, fish meal, molasses, oligosaccharides,
Sorghum, seed and cereal (come from such as corn, oat, rye, barley, wheat, it is complete or by the systems such as crushing, grinding
It is standby), oily seed cake of press is (such as from cottonseed, safflower, sunflower, soybean (such as soy meal), rapeseed, peanut or fallen flowers
It is raw), palm kernel cake, the substance of yeast sources and vinasse (such as wet vinasse (WDS) and distiller's dried grain (DDGS) containing soluble matter).
The European production efficiency factor (EPEF):The European production efficiency factor is to compare a kind of mode of animal performance.The list
One number helps to compare performance between farm inside farm, and can be used for Evaluation Environment, weather and management variable.EPEF
It is calculated as [(survival rate (%) × live-weight (kg))/(service life (day) × FCR when exhausting)] × 100, wherein survival rate is to slaughter
The percentage of surviving animals when government official, live-weight are the average weights of animal when butchering, and exhaust the service life that the service life is animal when butchering,
FCR is feed conversion rate when butchering.
Feed conversion rate (FCR):FCR is measurement of the animal by feed material conversion for the increased efficiency of desired output.It is right
In the domesticated animal (such as pig, poultry and fish) in order to meat, the output is the increased quality of animal.Specifically, FCR
It is calculated as:The weightening in feed divided by set period taken in set period.FCR improvement means the reduction of FCR values.FCR
Improving 2% means that FCR reduces 2%.
Segment:Term " segment " refers to amino from mature polypeptide or structural domain and/or carboxyl-terminal deletion one or more
The polypeptide or catalyst structure domain of multiple (such as several) amino acid;The wherein described segment has lysozyme or phytase activity.
On one side, segment includes SEQ ID NO:1 at least 170 amino acid, such as at least 175 amino acid, at least 177 ammonia
Base acid, at least 180 amino acid, at least 185 amino acid, at least 190 amino acid, at least 195 amino acid or at least 200
A amino acid and have lysozyme activity.
On the other hand, segment includes SEQ ID NO:4 at least 210 amino acid, such as at least 215 amino
Acid, at least 220 amino acid, at least 225 amino acid, at least 230 amino acid, at least 235 amino acid or at least 240
Amino acid and have lysozyme activity.
It is separated:Term " separated " refers to the substance in the form being not present in nature or environment.Through
The non-limiting examples of the substance of separation include (1) any non-naturally occurring substance, and (2) include but not limited to any enzyme, change
Any substance of body, nucleic acid, protein, peptide or co-factor, the associated one or more at least partly from nature
It is taken out in kind or all naturally occurring ingredients;(3) pass through manually modified any object relative to the substance found in nature
Matter;Or any substance (example that (4) are modified by relative to the amount of the substance is increased with its natural relevant other components
Such as, multiple copies of the gene of the substance are encoded;Using than with encode the substance gene naturally relevant promoter is stronger
Promoter).Separated substance may be present in fermentation broth sample.
Lysozyme activity:Term " lysozyme activity " means N- acetylmuramic acids and the Portugals N- acetyl group-D- in peptide glycan
The hydrolysis of Isosorbide-5-Nitrae-β-key between glucosamine residue and chitosan between N- acetyl group-d-glucosamine residue, leads to cell
Dissolving.Lysozyme belongs to the other EC 3.2.1.17 of enzyme.Lysozyme activity is usually measured by turbidimetric assay.This method is based on
The turbidity of 4698 suspended matters of Micrococcus luteus ATCC caused by splitting action by lysozyme changes.Suitable
Under experiment condition, these variations are proportional to the amount of lysozyme in culture medium (to advise referring to FAO's food additives
The INS 1105 (www.fao.org) that model Symphyla is wanted).For the purposes of the present invention, the turbidity described in embodiment 5 is surveyed
(" measurement of lysozyme activity ") is determined to measure lysozyme activity.In one aspect, polypeptide of the invention has SEQ ID NO:1
Lysozyme activity at least 20%, for example, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least
90%, at least 95% or at least 100%.On the other hand, polypeptide of the invention has SEQ ID NO:4 lysozyme activity
At least 20%, for example, at least 40%, at least 50%, at least 60%%, at least 70%, at least 80%, at least 90%, at least
95% or at least 100%.
Mature polypeptide:Term " mature polypeptide " refers to translation and any posttranslational modification (such as processing of the ends N-, the ends C- section
Short, glycosylation, phosphorylation etc.) after final form polypeptide.
Microbic muramidase:Term " microbic muramidase " refers to the polypeptide for having lysozyme activity, is obtained from or can obtain
From microbe-derived.Microbe-derived example has fungi.Specifically, microbic muramidase be obtained from or available from
Ascoycota, such as Pezizomycotina subphylums.
Sequence identity:Correlation between two amino acid sequences or between two nucleotide sequences is by parameter " sequence
Homogeneity " describes.
For the purposes of the present invention, using EMBOSS packets (EMBOSS:The European Molecular Biology
Open Software Suite, Rice et al., 2000, Trends Genet.16:276-277), preferred version 5.0.0 or more
Implement in the Needle programs of highest version Needleman-Wunsch algorithms (Needleman and Wunsch, 1970,
J.Mol.Biol.48:443-453) determine the sequence identity between two amino acid sequences.Parameter used is that vacancy opens
Point penalty 10, gap extension penalties 0.5 and EBLOSUM62 (the EMBOSS versions of BLOSUM62) substitute matrix.Needle is labeled as
The output (acquisition of use-nobrief options) of " longest homogeneity " is used as homogeneity percentage, following to calculate:
(identical residue × 100)/(comparing the vacancy sum in length-comparison).
Substantially pure polypeptide:Term " substantially pure polypeptide " refers to such product, contain at most 10 weight %,
At most 8 weight %, at most 6 weight %, at most 5 weight %, at most 4 weight %, at most 3 weight %, at most 2 weight %, at most 1
Weight % and at most 0.5 weight %'s natively or recombinates other relevant peptide materials with it.It is preferably based in product
The weight of existing total peptide material, the polypeptide are at least 92% pure, and for example, at least 94% is pure, at least 95% pure, at least
96% is pure, at least 97% pure, at least 98% pure, at least 99% pure, at least 99.5% pure and mild 100% pure.The polypeptide of the present invention is excellent
It is selected as substantially pure form.This can rely on for example prepares polypeptide by well known recombination method or by classical purification process
To realize.
Variant:Term " variant " means the polypeptide with lysozyme or phytase activity, in one or more (examples
Such as, several) change that includes one or more (several) amino acid residues at position, that is, it replaces, be inserted into and missing.Replacement is
Refer to the amino acid to plant oneself to be substituted by different amino acid;Missing refers to the amino acid that removal plants oneself;Insertion refers to neighbour
Amino acid that is close and and then planting oneself adds 1,2 or 3 amino acid.
In one aspect, bacteriolyze enzyme variants according to the present invention can include 1-5;1-10;1-15;1-20;1-25;1-
30;1-35;1-40;1-45;Or 1-50, i.e., 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,
20、21、22、23、24、25、26、27、28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、
45,46,47,48,49 or 50 changes, and there is parent's phytase (such as SEQ ID NO:1) phytase activity is at least
20%, for example, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least
100%.On the other hand, bacteriolyze enzyme variants according to the present invention can include 1-5;1-10;1-15;1-20;1-25;1-30;
1-35;1-40;1-45;Or 1-50, i.e., 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21、22、23、24、25、26、27、28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、45、
46,47,48,49 or 50 changes, and there is parent's lysozyme (such as SEQ ID NO:4) lysozyme activity is at least
20%, for example, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least
100%.
Detailed description of the invention
Specifically, present inventor it was unexpectedly found that:Compound combination according to the present invention is to cold aqueous
It is effective with many pathogenic gram-positive microorganisms of warm water fish.Show that composition according to the present invention is shown pair
Lactococcus garvieae (especially a kind of found in cold water fish disease) and to Streptococcus iniae
The inhibiting effect of (a kind of disease especially found in warm water fish).
In addition, at least one antimicrobial polypeptide with lysozyme activity is applied in combination as described above further improves day
The existing inhibiting effect of right essential oil active matter.
The known inhibiting effect of essential oil has:
Display australene, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene are shown to Aeromonas
The inhibiting effect of salmonicida, Aeromonas salmonicida are the pathogen for the disease for causing to be referred to as dothienesis.
Display australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene are shown pair
The inhibiting effect of Edwardsel-lia tarda, Edwardsel-lia tarda cause fish general infection.
Display australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol and terpinolene are shown pair
The inhibiting effect of Lactococcus garvieae, Lactococcus garvieae are the pathogen of Latococcosis,
Latococcosis is a kind of sudden illness, when water temperature increases above 16 DEG C in summer months, influences many fish objects
It plants and all causes heavy economic losses in seawater and fresh water aquaculture.
Cinnamic acid, dihydroeugenol, eugenol and metacresol show the excellent suppression to Yersinia ruckeri growths
It makes and uses, Yersinia ruckeri are the pathogenic microorganisms that one kind causing intestines red-mouth disease (ERM), and ERM is that a kind of be especially exists
The disease found in salmon.
Display cinnamic acid and metacresol are shown for inhibiting effect below:
- Vibrio salmonicida are psychrophilic bacterias, are the causative agents of atlantic salmon cold water vibriosis;
- Aeromonas hydrophila, cause ulcer and bovine pasteurellosis.This pathogen is to conventional simple
The resistance of antimicrobial (such as chlorine) is very big;
- Photobacterium damselae are formerly referred to as Pasteurella piscicida, are economically heavy
The high pathogen lost, for example Japanese Yellowtail of the economically important fish are caused in the marine fish culture industry wanted
(seriola) and epinephelus akaara (red grouper) and the striped perch (striped bass) and sciaenoid in the U.S.
(white perch);
- Streptococcus iniae are high pathogenic in fish and are high lethal:Outburst can be with 30-
50% death rate is associated with.
Other water-borne pathogens can also be inhibited by compound mixture of the present invention, such as
- Piscirickettsia salmonis are piscirickettsiosis or salmons septicaemia
(SRS) causative agent,
- Vibrio viscosus are renamed into Moritella viscosa, are known as in teiology recently
The reason of disease of " winter ulcer ",
- Ich (parasite) is one of most common fish protozoon parasite,
- Vibrio harveyi are the reason of causing photism vibriosis, and photism vibriosis is a kind of influence business
Cultivate the disease of shrimp.
In second aspect, the present invention provides a kind of fish feed compositions, and it includes at least one to have lysozyme activity
Microbial polypeptide with selected from australene (CAS 99-86-5), α-terpineol (CAS98-55-5), cinnamic acid (CAS 14371-10-
9/104-55-2), dihydroeugenol (CAS2785-87-7), eugenol (CAS 97-53-0), cresols (CAS 108-39-4) and
The combination of at least two reactive compounds of terpinolene (CAS 554-61-0).Compound according to the present invention is commercially available, or
Person can easily be prepared by those skilled in the art using technique commonly known in the art and method.
As fish feed composition, the compound of the present invention can be used alone or be used with its mixture, naturally may be used
Obtain the form of extract or extract mixtures or in the form of natural materials.
The term as used herein " extract " include the composition (also referred to as " extract oil ") obtained by solvent extraction,
It is method known to those skilled in the art by the composition (also referred to as " essential oil ") of steam distillation acquisition or by other
The composition of acquisition.Suitable Extraction solvent includes alcohols, such as ethyl alcohol.
Term " natural " is herein understood to be made of following compounds, and the compound is naturally occurring and from day
Right product is obtained or is obtained by synthesizing.
A small amount of other ingredients can be added into active essential oil compounds or natural materials or extract.These ingredients
Example has:Capsaicine, tannic acid, pipering, trimethylamine, 3,4, dimethlbenzene, furfuryl alcohol and its mixture.
The mixture of at least two essential oil compounds if as described above is preferred, then cinnamic acid and/or metacresol
It is used as the key component of mixture.Suitably, mixture contains the metacresol and/or cinnamic acid of 10-90 weight %, 1-50 weights
The australene of %, the dihydroeugenol of 1-50 weight % are measured, wherein total amount of the amount based on the component calculates.These activity
The total amount of ingredient can change in a wide range, but 10-5000ppm, preferably 100-1000ppm are finally used in fish meal,
Dry weight of the amount based on fish meal calculates.
The most preferred mixture of at least two essential oil compounds as described above includes cinnamic acid and australene as mixing
The key component of object.Suitably, mixture includes the australene of 30-70 weight %, the cinnamic acid of 30-70 weight %, 1-20 weights
The metacresol of %, the dihydroeugenol of 1-20 weight % are measured, wherein total amount of the amount based on the component calculates.These activity
The total amount of ingredient can change in a wide range, but 10-5000ppm, preferably 100-1000ppm are finally used in fish meal,
Dry weight of the amount based on fish meal calculates.
All essential oil compounds (reactive compound and added ingredient) being defined above can be with emulsifying surfactant group
It closes and uses.Emulsifier can be selected advantageously from those quite hydrophilic emulsifiers, for example, aliphatic acid polyglycerol ester, example
The ricinoleic acid of such as esterification or propylene glycol ester of aliphatic acid, sugared -ester class or sugar-glyceride type, polyethylene glycol, lecithin.
In a preferred embodiment of the present invention, blend of essential oils can contain the cinnamic acid of 20 weight %, 20 weights
Measure the metacresol of %, the dihydroeugenol of 20 weight %, the australene of 20 weight %, the trimethylamine of 3 weight %, 1.8 weight %
Pipering and 4 weight % furfuryl alcohol.
In another preferred embodiment of the present invention, the mixture of essential oil reactive compound includes 40-60 weight %
Australene, the cinnamic acid of 40-60 weight %, and the trimethylamine of 1-5 weight %, the pepper of 1-5% can be further included
The furfuryl alcohol of alkali and 3-8 weight %.
As described above, having unexpectedly discovered that:With microbic muramidase supplement animal feed in aquatic animal (including fish
And shrimp) in produce significant performance benefit.This is unexpected because using microbic muramidase improve animal performance with
It is preceding to be never proved.
Therefore, the invention further relates to a kind of method improving the European production efficiency factor (EPEF), the method includes:To
Animal applies animal feed or animal feed comprising at least two essential oil compounds and one or more of microbic muramidases
Additive.
In one preferred embodiment, animal feed or the animal that will improve with microbic muramidase is wherein not present
Feed addictive (herein referred as compareing) is compared.
In one embodiment, compared with the control, EPEF improves at least 1%, and such as at least 1.5%, at least
2.0%, at least 2.5%, at least 3%, at least 3.5%, at least 4% or at least 5%.In another embodiment, with compare
It comparing, EPEF improves 1%-15%, such as 1%-12%, 1%-10%, 1.5%-8%, 2.0%-7% or these sections
Any combinations.
In one embodiment, with every kg animal feeds 8-250ppm zymoproteins, such as per kg animal feeds 9-
200ppm, 10-150ppm, 11-125ppm, 12-100ppm, 13-75ppm, 15-50ppm, 17.5-40ppm, 25-75ppm or
30-60ppm zymoproteins or any combination of horizontal dispensing microbic muramidase in these sections.
In one embodiment, microbic muramidase is originated from fungus.In one embodiment, microorganism bacteriolyze
Enzyme is obtained from or available from Ascoycota, such as Pezizomycotina subphylums.
In one embodiment, microbic muramidase includes one or more structural domains selected from GH24 and GH25.
In one preferred embodiment, the present invention relates to a kind of European production efficiency factor (EPEF) of improvement and/or
The method of feed conversion rate (FCR), the method includes:The animal for including one or more of microbic muramidases is applied to fish
Feed or animal feed additive, wherein:
(a) microbic muramidase is that the microorganism comprising one or more structural domains selected from GH24 and GH25 is molten
Bacterium enzyme, with the horizontal dispensing of every kg animal feeds 10-150ppm zymoproteins;
(b) aquatic animal is to be selected from shrimp, cold water fish such as salmon, bream, perch and warm water fish such as carp,
Tilapia mossambica, catfish, and;
(c) compared with the control, the European production efficiency factor (EPEF) and/or feed conversion rate (FCR) improve at least 1%.
In one embodiment, microbic muramidase is originated from fungus.In one embodiment, microorganism bacteriolyze
Enzyme is obtained from or available from Ascoycota, such as Pezizomycotina subphylums.
In one embodiment, microbic muramidase and SEQ ID NO:1 have at least 50%, for example, at least 60%,
At least 70%, at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least
90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%,
At least 99% or 100% sequence identity.
In one embodiment, microbic muramidase includes SEQ ID NO:1 amino acid sequence or its allelic variant
Or by SEQ ID NO:1 amino acid sequence or its allelic variant composition;Either SEQ ID NO:1 amino acid sequence
Segment with lysozyme activity, wherein the segment includes at least 170 amino acid, for example, at least 175 amino acid, at least
177 amino acid, at least 180 amino acid, at least 185 amino acid, at least 190 amino acid, at least 195 amino acid or
At least 200 amino acid.In another embodiment, microbic muramidase includes SEQ ID NO:1 amino acid sequence or
Its allelic variant and the ends N- and/or C- terminal His tags and/or HQ labels or by SEQ ID NO:1 amino acid sequence
Row or its allelic variant and the ends N- and/or C- terminal His tags and/or HQ labels composition.On the other hand, polypeptide includes
SEQ ID NO:1 amino acid 1-208 is made from it.
In another embodiment, microbic muramidase is SEQ ID NO:1 variant, wherein the variant is with molten
Bacterium enzymatic activity and 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,
25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49 or
50 positions include one or more replacements and/or one or more missings and/or one or more insertions or its
What is combined.In another embodiment, SEQ ID NO:In 1 comprising one or more amino acid substitutions and/or one or
More amino acid deletions and/or one or more amino acid be inserted into or any combination thereof the number of position be 1-45, example
Such as 1-40,1-35,1-30,1-25,1-20,1-15,1-10 or 1-5 positions.In one embodiment, SEQ ID NO:1
In include one or more amino acid substitutions and/or one or more amino acid deletions and/or one or more amino
Acid be inserted into or any combination thereof the number of position be no more than 10, such as 1,2,3,4,5,6,7,8,9 or 10.In another implementation
In mode, SEQ ID NO:The number of replacement, deletion and/or insertion in 1 is no more than 10, such as 1,2,3,4,5,6,7,8,9
Or 10.In another embodiment, SEQ ID NO:Replacement in 1, the preferably conservative number replaced be no more than 10, such as 1,
2,3,4,5,6,7,8,9 or 10.In another embodiment, SEQ ID NO:The number replaced is guarded in 1 is no more than 10, example
Such as 1,2,3,4,5,6,7,8,9 or 10.
Amino acid change can be not too important to property, i.e., does not significantly affect the folding of protein and/or active conservative
Amino acid substitution or insertion;The small missing of usual 1-30 amino acid;Small amino-or carboxyl-tenninus extend, such as amino-
Terminus methionine residue;The small connection peptide of at most 20-25 residue;Or it is pure to promote by changing net charge or other functions
The small extension changed, such as polyhistidine beam, epitope or binding domain.
The conservative example replaced is with the following group:Basic amino acid group (arginine, lysine and histidine), acid ammonia
Base acid group (glutamic acid and aspartic acid), polar amino acid group (glutamine and asparagine), hydrophobic amino acid group (bright ammonia
Acid, isoleucine and valine), aromatic amino acid group (phenylalanine, tryptophan and tyrosine) and p1 amino acid group (sweet ammonia
Acid, alanine, serine, threonine and methionine).The amino of specific activity (specific activity) is not changed usually
It is known in the art that acid, which is replaced, and for example by H.Neurath and R.L.Hill, and 1979 in The Proteins,
Described in Academic Press, New York.Common replacement has Ala/Ser, Val/Ile, Asp/Glu, Thr/Ser, Ala/
Gly、Ala/Thr、Ser/Asn、Ala/Val、Ser/Gly、Tyr/Phe、Ala/Pro、Lys/Arg、Asp/Asn、Leu/Ile、
Leu/Val, Ala/Glu and Asp/Gly.
Can according to program known in the art such as direct mutagenesis or alanine scanning mutagenesis (Cunningham and Wells,
1989,Science 244:1081-1085) identify the essential amino acid in polypeptide.In latter technique, in the every of molecule
Single alanine mutation is introduced at a residue, and detects the lysozyme activity of gained mutating molecule, to identify for molecular activity
Crucial amino acid residue.Referring to Hilton etc., 1996, J.Biol.Chem.271:4699-4708.The active site of enzyme or its
Its biological interaction can also be determined by the physical analysis to structure, such as pass through these following technologies:Such as nuclear-magnetism is total
It shakes, crystallography, electronic diffraction or photoaffinity labeling, is determined together with the mutation of the contact site amino acids of presumption.See, for example,
De Vos etc., 1992, Science 255:306-312;Smith et al.,1992,J.Mol.Biol.224:899-904;
Wlodaver et al.,1992,FEBS Lett.309:59-64.The homogeneity of essential amino acid can also from related polypeptide
Comparison infer.
As disclosed in WO2013/076253, withResolution ratio cracked Acremonium alcalophilum
The crystal structure of CBS114.92 lysozymes.These atomic coordinates, which can be used for generating, describes Acremonium alcalophilum
The threedimensional model of the structure or homologous structure (such as variant of the present invention) of CBS114.92 lysozymes.It, will using x/ ray structures
Amino acid residue D95 and E97 (use SEQ ID NO:1 number) it is accredited as catalytic residue.
In one embodiment, microbic muramidase and SEQ ID NO:4 have at least 50%, for example, at least 60%,
At least 70%, at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least
90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%,
At least 99% or 100% sequence identity.
In one embodiment, microbic muramidase includes SEQ ID NO:4 amino acid sequence or its allelic variant
Or by SEQ ID NO:4 amino acid sequence or its allelic variant composition;Either SEQ ID NO:4 amino acid sequence
Segment with lysozyme activity, wherein the segment includes at least 210 amino acid, for example, at least 215 amino acid, at least
220 amino acid, at least 225 amino acid, at least 230 amino acid, at least 235 amino acid or at least 240 amino acid.
In another embodiment, microbic muramidase includes SEQ ID NO:4 amino acid sequence or its allelic variant and N-
End and/or C- terminal His tags and/or HQ labels or by SEQ ID NO:4 amino acid sequence or its allelic variant with
And the ends N- and/or C- terminal His tags and/or HQ labels composition.On the other hand, polypeptide includes SEQ ID NO:4 amino
Sour 1-245 is made from it.
In another embodiment, microbic muramidase is SEQ ID NO:4 variant, wherein the variant is with molten
Bacterium enzymatic activity and 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,
25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49 or
50 positions include one or more replacements and/or one or more missings and/or one or more insertions or its
What is combined.In another embodiment, SEQ ID NO:In 4 comprising one or more amino acid substitutions and/or one or
More amino acid deletions and/or one or more amino acid be inserted into or any combination thereof the number of position be 1-45, example
Such as 1-40,1-35,1-30,1-25,1-20,1-15,1-10 or 1-5 positions.In one embodiment, SEQ ID NO:4
In include one or more amino acid substitutions and/or one or more amino acid deletions and/or one or more amino
Acid be inserted into or any combination thereof the number of position be no more than 10, such as 1,2,3,4,5,6,7,8,9 or 10.In another implementation
In mode, SEQ ID NO:The number of replacement, deletion and/or insertion in 4 is no more than 10, such as 1,2,3,4,5,6,7,8,9
Or 10.In another embodiment, SEQ ID NO:Replacement in 4, the preferably conservative number replaced be no more than 10, such as 1,
2,3,4,5,6,7,8,9 or 10.In another embodiment, SEQ ID NO:The number replaced is guarded in 4 is no more than 10, example
Such as 1,2,3,4,5,6,7,8,9 or 10.
Described above is amino acid change, the examples of conservative replacement and N- and/or C- end fittings.
The enzyme of the present invention can be formulated into liquid or solid.For liquid preparation, preparaton may include that polyalcohol is (such as sweet
Oil, ethylene glycol or propylene glycol), salt (such as sodium chloride, sodium benzoate, potassium sorbate) or sugar or sugar derivatives (such as dextrin, Portugal
Grape sugar, sucrose and D-sorbite).Therefore, in one embodiment, composition is enzyme and one or more comprising the present invention
The liquid composition of kind of preparaton, the preparaton be selected from glycerine, ethylene glycol, 1,2-PD, 1,3-PD, sodium chloride,
Sodium benzoate, potassium sorbate, dextrin, glucose, sucrose and D-sorbite.Liquid preparation can be sprayed onto after granulation on feed,
Or it can be added in the drinking water for giving animal.
For solid pharmaceutical preparation, preparation can be such as particle, spray-dried powders or agglomerate.Preparaton can include salt
(zinc salt, sodium salt, sylvite or the calcium salt of organic or inorganic, for example, calcium acetate, calcium benzoate, calcium carbonate, calcium chloride, calcium citrate,
Calcium sorbate, calcium sulfate, potassium acetate, Potassium Benzoate, potassium carbonate, potassium chloride, potassium citrate, potassium sorbate, potassium sulfate, acetic acid
Sodium, sodium benzoate, sodium carbonate, sodium chloride, sodium citrate, sodium sulphate, zinc acetate, zinc benzoate, zinc carbonate, zinc chloride, lemon
Sour zinc, sorbic acid zinc, zinc sulfate), starch or sugar or sugar derivatives (such as sucrose, dextrin, glucose, lactose, D-sorbite).
In one embodiment, solid composite is in granular form.Particle can have matrix structure, wherein each component
Uniformly mixing.But particle generally comprises core particle and one or more of coatings, the coating is typically salt and/or wax
Coating.Core particle can be that the enzyme of the present invention optionally combines and with one or more of other enzymes optionally together with one
The homogeneous blend of kind or more salt;Either inert particulate, wherein the present invention enzyme optionally with coating on it one
The other enzyme combination of kind or more.
In one embodiment, the material of core particle be selected from inorganic salts (such as calcium acetate, calcium benzoate, calcium carbonate,
Calcium chloride, calcium citrate, calcium sorbate, calcium sulfate, potassium acetate, Potassium Benzoate, potassium carbonate, potassium chloride, potassium citrate, sorbic acid
Potassium, potassium sulfate, sodium acetate, sodium benzoate, sodium carbonate, sodium chloride, sodium citrate, sodium sulphate, zinc acetate, zinc benzoate, carbonic acid
Zinc, zinc chloride, zinc citrate, sorbic acid zinc, zinc sulfate), starch or sugar or sugar derivatives (such as sucrose, dextrin, glucose,
Lactose, D-sorbite), sugar or sugar derivatives (such as sucrose, dextrin, glucose, lactose, D-sorbite), small organic molecule,
Starch, powder, cellulose and minerals.
Salt coating typically at least 1 μ m-thick, and can be the mixture of a kind of specific salt or salt, such as Na2SO4、
K2SO4、MgSO4And/or sodium citrate.Other examples are such as WO 2008/017659, WO 2006/034710, WO 1997/
05245, WO 1998/54980, WO 1998/55599, those of described in WO 2000/70034 or such as WO 2001/
Polymer coating described in 00042.
In another embodiment, composition is solid composite, and it includes the enzyme of the present invention and one or more
Preparaton, the preparaton are selected from sodium chloride, sodium benzoate, potassium sorbate, sodium sulphate, potassium sulfate, magnesium sulfate, thiosulfuric acid
Sodium, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, D-sorbite, lactose, starch and cellulose.It is preferred real at one
It applies in mode, preparaton is selected from one or more of following compounds:Sodium sulphate, dextrin, cellulose, sodium thiosulfate and carbonic acid
Calcium.In one preferred embodiment, solid composite is in granular form.In one embodiment, solid composite is in
Particle form and include core particle, include the present invention enzyme enzyme layer and salt coating.
In another embodiment, preparaton is selected from one or more of following compounds:Glycerine, ethylene glycol, 1,2-
Propylene glycol or 1,3- propylene glycol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulphate, potassium sulfate, magnesium sulfate, sodium thiosulfate,
Calcium carbonate, sodium citrate, dextrin, glucose, sucrose, D-sorbite, lactose, starch and cellulose.In a preferred implementation
In mode, preparaton is selected from one or more of following compounds:1,2- propylene glycol, 1,3- propylene glycol, sodium sulphate, dextrin, fibre
Dimension element, sodium thiosulfate and calcium carbonate.
The fish feed composition containing reactive compound can be mixed in fish meal as described in example 1 above.Then will
The mixture of reactive compound is directly prepared into oil, then mixes the oil with the oil being sprayed onto on feed pellets, such as embodiment 1
Described in.
Or it can be by preparing the pre-composition of active constituent and other suitable additives to which reactive compound will be contained
Fish feed composition incorporation fish meal in.This pre-composition can include the active mixture or natural goods of 2-10 weight %
Matter or extract, other conventional additives such as flavoring agent of 0-40 weight % and any Conventional absorbent of 50-98 weight % carry
Body (support).
Carrier can contain the wood-fibred of such as 40-50 weight %, the tristearin of 8-10 weight %, the turmeric of 4-5 weight %
Powder, the rosemary powder of 4-5 weight %, the lime stone of 22-28 weight %, the natural gum such as gum arabic of 1-3% weight, 5-50%
The water of the sugar and/or starch and 5-15% weight of weight.
Then by the pre-composition and vitamin (such as vitamin C), mineral salt and other feed addictive ingredients (such as containing
Have the yeast extract of nucleotide, glucan and other intestinal microflora conditioning agents) mixing, it is then final so that feed
The amount of active constituent according to the present invention containing 10-5000ppm, preferably 100-1000ppm or 100-500ppm is added to
In feed.
In addition, the composition of the present invention is preferably used together with containing nucleotide with the yeast extract of glucan.
In addition, optional feed addictive ingredient is colorant, for example, carotenoid such as beta carotene, astaxanthin and
Lutein;Aromatic compound;Stabilizer;Antimicrobial peptide;Polyunsaturated fatty acid;And/or it is at least one selected from phytase (EC
3.1.3.8 or 3.1.3.26);Zytase (EC 3.2.1.8);Galactanase (EC 3.2.1.89);Alpha-galactosidase
(EC 3.2.1.22);Protease (EC 3.4.);Phospholipase A1 (EC 3.1.1.32);Phospholipase A2 (EC 3.1.1.4);Haemolysis
Phosphatidase (EC 3.1.1.5);Phospholipase C (EC 3.1.4.3);Phospholipase D (EC 3.1.4.4);Amylase, such as alphalise starch
Enzyme (EC 3.2.1.1);And/or the enzyme of 1,4 beta-glucanase (EC 3.2.1.4 or EC 3.2.1.6).
The example of polyunsaturated fatty acid has C18, C20 and C22 polyunsaturated fatty acid, such as arachidonic acid, 22
Carbon acid, eicosapentaenoic acid and gamma-linoleic acid.
Fish meal as described herein with 20-60 weight % protein and 1-45 weight % moisture and lipid it is close
Like composition.
In some specific examples, fish meal includes the source of one or more of following substances:
Protein, carbohydrate and lipid (such as fish meal, fish oil, blood meal, feather meal, poultry powder, chicken powder and/or by
The other kinds of powder that other slaughterhouse wastes generate);
Animal tallow (such as poultry oil);
Vegetable powder (such as soy meal, feather fan bean powder, peameal, bean powder, ground oil seeds and/or sunflower powder);
Vegetable oil (such as rapeseed oil, soybean oil);
Seitan (such as gluten or corn gluten) and
The amino acid (such as lysine) of addition.
The term as used herein " fish meal " includes fish feed composition according to the present invention and component as described above.It is logical
Often, fish meal includes fish meal as component.Suitably, fish meal is in the form of sheets or pellet (such as squeezing out pellet) form.
In the third aspect, the present invention relates to for aquatic animal fodder compound and the composition for feeding fish
Purposes.This feed is particularly suitable for feeding salmon, including atlantic salmon (Ontario salmon (Salmo salar)), other salmons
Fish species and trout and non-salmon such as gadus, perch, madai and sea eel.However, this feed can feed it is all types of
Fish, such as turbot, halibut, Yellow Tail (yellow tail) and tuna.
Described and claimed herein is not limited in range by particular implementation disclosed herein, because
These embodiments are intended as the explaination of several aspects of the invention.Any equivalent embodiment is intended to the present invention's
In range.It is of the invention various to repair other than those modifications shown and described herein in fact, according to the description of front
Change and is apparent to practitioners skilled in the art.These modifications are also intended to fall within the scope of the appended claims.
Embodiment 1:Suppress the preparation of fish meal
Main raw material(s) is ground and mixed.Then micro constitutent is added in mixer, and by into preprocessor
Material in addition water and steam adjust homogeneous mixture.This has started the cooking in starch fraction (binding component)
(cooking) process.Material is fed in granulator.Mold of the material by granulator is forced, and will in the outside of mold
Thread (string) is broken into pellet.Moisture is low, therefore dry feed is not required.
Then the other oil comprising fish feed composition according to the present invention is sprayed onto on pellet surface, but due to pellet
It is quite fine and close, so total lipid content rarely exceeds 24%.The oil of addition can be fish oil or vegetable oil, such as rapeseed oil or beans
The mixture of the mixture or fish oil and vegetable oil of oil or vegetable oil.After oil cladding, pellet is cooled down and filled in cooler
Bag.Final compacting fish meal contains the composition of the present invention of 10-5000ppm.
Embodiment 2:The method for preparing extruding fish feed
Main raw material(s) is ground and mixed.Then the micro constitutent comprising fish feed composition according to the present invention is added
Enter in mixer.Homogeneous mixture is adjusted by adding water and steam in the material into preprocessor.It is gone back in this stage
Additional oil can be added into material.This has started boiling (cooking) process in starch fraction (binding component).By object
Material is fed in extruder.Extruder can be single-bolt type or double-screw type.Due to the rotary motion of material in an extruder,
Material is further mixed.Additional oil, water and steam can be added into the material in extruder.In the end of extruder, object
Expect that there is the temperature higher than 100 DEG C and the pressure higher than environmental pressure.Material is forced to pass through the opening in extruder template.Due to
The release of temperature and pressure, some moisture can evaporate (flash distillation) immediately, therefore extruded material becomes porous.By rotating knife by line
Shape object is cut into pellet.Water content is quite high (18-28%), therefore immediately contains the water that pellet is dried to about 10% in drier
Amount.
It, can be by the way that oil be sprayed onto on feed surface or by the way that feed is dipped in oil, thus to feeding after drier
More oil are added in material.Oil is added in feed (vacuum coated) in closed container of the wherein air pressure less than environmental pressure
It is advantageous, this makes porous feed pellets absorb more heavy wool.It can be in this way containing the feed for having more than 40% lipid
Production.After coating machine, by feed cooling and pack.In method as described above, oil can be added in several positions, and
And can be fish oil or vegetable oil, such as the mixture of the mixture or fish oil and vegetable oil of rapeseed oil or soya-bean oil or vegetable oil.
In order to grow and keep good health state, fish to need protein, fat, minerals and vitamins.Eat meat fish
Diet it is especially important.Initially, in the cultivation of carnivorous fish, full fish (whole fish) or broken fish (ground fish) are used
To meet the nutritional need of cultivation fish.The broken fish mixed with various dry raw materials (such as fish meal and starch) is referred to as soft feed or half
Moist forage.With aquaculture industry, soft feed or semi-wet feed are pressed dry feed replacement.Its own is gradually extruded dry feed
It substitutes.
Nowadays, feed is squeezed out in the cultivation of many fish species (such as various types of salmons, gadus, perch and madai)
It is almost universal.
Main protein source in the dry feed of fish is the fish meal of different qualities.Other animal protein sources are also used for doing
Fish meal.Therefore, using blood meal, bone meal, feather meal and the other kinds of powder such as chicken generated by other slaughterhouse wastes
Powder is known.They are usually cheaper than fish meal and fish oil.However, in some geographic areas, it is forbidden to use this kind of raw material life
Produce the feed of the animal and fish for producing food.
Use vegetable protein such as gluten, maize (corn) seitan, soybean protein, feather fan bean powder, peameal, beans
Powder, ground oil seeds, sunflower powder and rice flour are also known.
Embodiment 3:Assess reactive compound according to the present invention to Lactococcus garvieae and
The influence of the survival of Streptococcus iniae
The present composition is measured in vitro to resist Lactococcus garvieae and Streptococcus iniae
Microbial activity.
Feeding scheme:
1. individual lysozyme continues 48 hours
2. lysozyme continues 24 hours;Essential oil is added above, continues next 24 hours
3. mixing and adding lysozyme and essential oil, continue 48 hours
Lysozyme:007 batch 9PPL 38353T.reesei, 52g EP/kg of LBF
- 1/2 essential oil combination
50% α firpenes
50% cinnamic acid
In test, using following biology, growth medium, condition of culture and appraisal procedure:
Bacterium:The pathogenic strain of all detections belong to University of Bern (Switzerland) Veterinary Pathological Research fish and
The bacterial strain preservation in wild animal health center.
The determination of suitable bacterium dilution:It is thin from 24 hour age on sheep blood agar (Biomerieux, Geneva)
It is shifted in bacterium subculture in extremely sterile NaCl on a small quantity, until obtaining 0.5 McFarland values.Since the solution, having
There is the dilution that in TSB 3%, 1.5% and 0.75% is formed on 96 orifice plates of round bottom.Each hole receives 100 μ l total volumes.22
At DEG C after 24 hours, the growth of bacterium is assessed.The dilution for covering the apparent spot in boundary line of round bottom hole half is caused to be selected
For testing.
The measurement of solvent effect:The detection substance in TSB agar is dissolved using ethyl alcohol (ETOH).It can in order to determine ethyl alcohol
It can influence, using the ethyl alcohol final concentration (0.1%, 0.05% and 0.025%) calculated in the Bacteria Detection detection hole of various concentration,
Any influence to bacterial growth is not shown.
Detect the concentration of substance:In view of dietary concentration likely is at least 1000ppm and daily uptake ratio is
2%, estimate external dosage range.Potential concentration in enteron aisle is determined as 0.1 μ l/100 μ l of highest.Then detection series 2 is dilute
Degree of releasing, so as to cause the final concentration of 0.85 μ g/ml of substance;0.42 μ g/ml and 0.21 μ g/ml are (when being adjusted to average essential oil density
When).
From each substance, the liquid storage being made of 2 μ l substances, 18 μ l ETOH and 180 μ l PBS is prepared.
The preparation of plate:Detect three concentration (0.21 μ g/ml, 0.42 μ g/ml and 0.85 μ g/ml) each three of each substance
Part.Include the positive control and blank control (PBS) being made of the bacterium in TSB on every block of plate.Also include ETOH on every block of plate
Three dilution in addition each three parts.
The reading of plate:After being incubated 24 hours at 22 DEG C, using 0 point (no bacterial growth=hole bottom is without point) to 3 minutes (just
Be frequently grown=spot size is comparable to the spot size of positive control) read plate.
It obtains following result and summarizes in fig 1 and 2.
Claims (16)
1. at least one selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene
Natural active matter is used to improve the feed of aquatic animal with the combination of the polypeptide with lysozyme activity in fodder compound
The purposes of conversion ratio and/or daily gain.
2. selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene at least two
Natural active matter is used to adjust the enteron aisle of aquatic animal with the combination of the polypeptide with lysozyme activity in fodder compound
The purposes of microorganism species.
3. selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene at least two
Natural active matter with lysozyme activity polypeptide combination in fodder compound for reducing the aquatic animal death rate
Purposes.
4. purposes according to any one of claim 1-3, wherein the aquatic animal is cold water fish, such as salmon,
Trout, bream or perch.
5. according to the purposes described in any one of claim 1 or 3, wherein the aquatic animal is warm water fish, such as carp,
Tilapia mossambica or catfish.
6. purposes according to any one of claims 1-5, wherein the fodder compound contains australene and cinnamic acid.
7. purposes according to claim 6, wherein the fodder compound contain concentration every Kg feeds 10mg-5g it
Between australene, cinnamic acid, dihydroeugenol and metacresol.
8. purposes according to claim 6, wherein the fodder compound contain concentration every Kg feeds 0.1g-1g it
Between australene, cinnamic acid, dihydroeugenol and metacresol.
9. the purposes described in any one of claim 1-8, wherein the microbic muramidase is originated from fungus.
10. the purposes described in any one of claim 1-9, wherein the microbic muramidase be obtained from or available from
Ascomycota.
11. the purposes described in any one of claim 1-10, wherein the microbic muramidase be obtained from or available from
Pezizomycotina subphylums.
12. the purposes described in any one of claim 1-11, wherein the microbic muramidase includes one or more choosings
From the structural domain of GH24 and GH25.
13. the purposes described in any one of claim 1-12, wherein the microbic muramidase is selected from:
(a) with SEQ ID NO:1 have at least 50%, for example, at least 60%, at least 70%, at least 75%, at least 80%, at least
85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%,
At least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity it is more
Peptide;
(b)SEQ ID NO:1 variant, wherein the variant have lysozyme activity and 1,2,3,4,5,6,7,8,9,
10、11、12、13、14、15、16、17、18、19、20、21、22、23、24、25、26、27、28、29、30、31、32、33、34、
35,36,37,38,39,40,41,42,43,44,45,46,47,48,49 or 50 positions include one or more amino acid
It replaces and/or one or more amino acid deletions and/or one or more amino acid is inserted into;
(c) (a) with lysozyme activity or (b) segment of the polypeptide, wherein the segment includes at least 170 amino
Acid, for example, at least 175 amino acid, at least 177 amino acid, at least 180 amino acid, at least 185 amino acid, at least
190 amino acid, at least 195 amino acid or at least 200 amino acid;
(d) with SEQ ID NO:4 have at least 50%, for example, at least 60%, at least 70%, at least 75%, at least 80%, at least
85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%,
At least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% sequence identity it is more
Peptide;
(e)SEQ ID NO:4 variant, wherein the variant have lysozyme activity and 1,2,3,4,5,6,7,8,9,
10、11、12、13、14、15、16、17、18、19、20、21、22、23、24、25、26、27、28、29、30、31、32、33、34、
35,36,37,38,39,40,41,42,43,44,45,46,47,48,49 or 50 positions include one or more amino acid
It replaces and/or one or more amino acid deletions and/or one or more amino acid is inserted into;With
(f) (d) with lysozyme activity or (e) segment of the polypeptide, wherein the segment includes at least 210 amino
Acid, for example, at least 215 amino acid, at least 220 amino acid, at least 225 amino acid, at least 230 amino acid, at least
235 amino acid or at least 240 amino acid.
14. the purposes described in any one of claim 1-13, wherein the microbic muramidase is selected from SEQ ID NO:1 ammonia
Base acid 1-208 and SEQ ID NO:4 amino acid 1-245.
15. selected from australene, α-terpineol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene at least two
The combination of kind natural active matter and the polypeptide with lysozyme activity according to any one of claim 9-14 is used for
Treat and prevent the purposes of the disease caused by pathogenic microorganisms in aquatic animal.
16. for the fodder compound or premix composition or feed addictive of aquatic animal, it includes selected from australene, α-terpene
Product alcohol, cinnamic acid, dihydroeugenol, eugenol, metacresol and terpinolene at least two natural active matters with according to power
Profit requires the combination of the polypeptide with lysozyme activity described in any one of 9-14 as main component.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15189495.3 | 2015-10-13 | ||
EP15189495 | 2015-10-13 | ||
PCT/EP2016/074407 WO2017064092A1 (en) | 2015-10-13 | 2016-10-12 | Feed additives for aquatic animals comprising essential oils and lysozyme |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108289478A true CN108289478A (en) | 2018-07-17 |
Family
ID=54293139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201680058693.7A Pending CN108289478A (en) | 2015-10-13 | 2016-10-12 | Include the feed addictive for aquatic animal of essential oil and lysozyme |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3361882A1 (en) |
CN (1) | CN108289478A (en) |
CA (1) | CA3001389A1 (en) |
CL (1) | CL2018000925A1 (en) |
WO (1) | WO2017064092A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109170369A (en) * | 2018-10-10 | 2019-01-11 | 徐州市宏翔蛋白饲料有限公司 | A kind of formula of the bone powder fodder containing duck |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10945449B2 (en) | 2015-07-02 | 2021-03-16 | Novozymes A/S | Animal feed compositions and uses thereof |
AU2018264463B2 (en) * | 2017-05-12 | 2024-04-18 | Novozymes A/S | Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof |
MX2020006588A (en) * | 2017-12-20 | 2020-12-10 | Dsm Ip Assets Bv | Animal feed compositions comprising muramidase and uses thereof. |
CN111492053A (en) * | 2017-12-20 | 2020-08-04 | 帝斯曼知识产权资产管理有限公司 | Animal feed composition and use thereof |
CN112004417A (en) * | 2018-04-25 | 2020-11-27 | 诺维信公司 | Animal feed composition and use thereof |
CN109105665B (en) * | 2018-09-05 | 2022-05-17 | 山东大学 | Method for screening turbot feed protective agent |
BR112021004814A2 (en) * | 2018-09-17 | 2021-06-22 | Dsm Ip Assets B.V. | composition of animal feed and its use |
US20210289818A1 (en) * | 2018-09-17 | 2021-09-23 | Dsm Ip Assets B.V. | Animal feed compositions and uses thereof |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002316909A (en) * | 2000-12-22 | 2002-10-31 | Erubu:Kk | Functional material |
CN1946841A (en) * | 2004-04-23 | 2007-04-11 | 汉高两合股份公司 | Novel alkaline proteases, and detergents and cleaners containing the same |
CN101094734A (en) * | 2004-11-10 | 2007-12-26 | 丹尼斯科有限公司 | Antibacterial composition and methods thereof |
CN101331915A (en) * | 2007-06-29 | 2008-12-31 | 帝斯曼知识产权资产管理有限公司 | Animal feed composition |
US7504490B1 (en) * | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
US20090188005A1 (en) * | 2005-02-24 | 2009-07-23 | Boukharov Andrey A | Methods for genetic control of plant pest infestation and compositions thereof |
CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
EP2224918A1 (en) * | 2007-11-22 | 2010-09-08 | PHARMATÉKA Gyártó és Kereskedelmi BT | Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
CN102469808A (en) * | 2009-07-17 | 2012-05-23 | 帝斯曼知识产权资产管理有限公司 | Use of natural substances as feed additives for aquatic animals |
WO2013076253A1 (en) * | 2011-11-25 | 2013-05-30 | Novozymes A/S | Polypeptides having lysozyme activity and polynucleotides encoding same |
CN103571613A (en) * | 2012-08-06 | 2014-02-12 | 湖北大自然农业实业有限公司 | Preparation method of vitex negundo linn volatile oil |
CN104256194A (en) * | 2014-10-14 | 2015-01-07 | 湖南百宜饲料科技有限公司 | Functional life-saving pig creep feed containing milk powder |
CN104286420A (en) * | 2014-10-27 | 2015-01-21 | 天津市世昌科技发展有限公司 | Feed additive capable of improving farrowing and milk production performances of breeding fur-bearing animals and preparation method of feed additive |
CN104673558A (en) * | 2013-11-30 | 2015-06-03 | 楚乐然 | Acarus killing perfumed soap |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130101634A1 (en) * | 2011-10-12 | 2013-04-25 | Deerland Enzymes, Inc. | Compositions and methods for reducing microbial overgrowth in the small intestines |
-
2016
- 2016-10-12 CA CA3001389A patent/CA3001389A1/en not_active Abandoned
- 2016-10-12 EP EP16784817.5A patent/EP3361882A1/en not_active Withdrawn
- 2016-10-12 CN CN201680058693.7A patent/CN108289478A/en active Pending
- 2016-10-12 WO PCT/EP2016/074407 patent/WO2017064092A1/en active Application Filing
-
2018
- 2018-04-11 CL CL2018000925A patent/CL2018000925A1/en unknown
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7504490B1 (en) * | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
JP2002316909A (en) * | 2000-12-22 | 2002-10-31 | Erubu:Kk | Functional material |
CN1946841A (en) * | 2004-04-23 | 2007-04-11 | 汉高两合股份公司 | Novel alkaline proteases, and detergents and cleaners containing the same |
CN101094734A (en) * | 2004-11-10 | 2007-12-26 | 丹尼斯科有限公司 | Antibacterial composition and methods thereof |
US20090188005A1 (en) * | 2005-02-24 | 2009-07-23 | Boukharov Andrey A | Methods for genetic control of plant pest infestation and compositions thereof |
CN101331915A (en) * | 2007-06-29 | 2008-12-31 | 帝斯曼知识产权资产管理有限公司 | Animal feed composition |
EP2224918A1 (en) * | 2007-11-22 | 2010-09-08 | PHARMATÉKA Gyártó és Kereskedelmi BT | Use of edta and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases |
CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
CN102469808A (en) * | 2009-07-17 | 2012-05-23 | 帝斯曼知识产权资产管理有限公司 | Use of natural substances as feed additives for aquatic animals |
CN102469808B (en) * | 2009-07-17 | 2014-01-15 | 帝斯曼知识产权资产管理有限公司 | Use of natural substances as feed additives for aquatic animals |
WO2013076253A1 (en) * | 2011-11-25 | 2013-05-30 | Novozymes A/S | Polypeptides having lysozyme activity and polynucleotides encoding same |
CN103957929A (en) * | 2011-11-25 | 2014-07-30 | 诺维信公司 | Polypeptides having lysozyme activity and polynucleotides encoding same |
CN103571613A (en) * | 2012-08-06 | 2014-02-12 | 湖北大自然农业实业有限公司 | Preparation method of vitex negundo linn volatile oil |
CN104673558A (en) * | 2013-11-30 | 2015-06-03 | 楚乐然 | Acarus killing perfumed soap |
CN104256194A (en) * | 2014-10-14 | 2015-01-07 | 湖南百宜饲料科技有限公司 | Functional life-saving pig creep feed containing milk powder |
CN104286420A (en) * | 2014-10-27 | 2015-01-21 | 天津市世昌科技发展有限公司 | Feed additive capable of improving farrowing and milk production performances of breeding fur-bearing animals and preparation method of feed additive |
Non-Patent Citations (4)
Title |
---|
S. SIAVASH SAEI-DEHKORDI等: "Chemical composition, antioxidative capacity and interactive", 《INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY》 * |
STEFANIE TRAEGER等: "The genome and development dependent transcriptomes of pyronema confluens:a window into fungal evolution", 《PLOS GENETICS》 * |
Z.L. ZHENG等: "Evaluation of oregano essential oil (Origanum heracleoticum L.) on growth,", 《AQUACULTURE》 * |
王光锋等: "补体和溶菌酶在清除文昌鱼体内细菌中的作用", 《水产科学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109170369A (en) * | 2018-10-10 | 2019-01-11 | 徐州市宏翔蛋白饲料有限公司 | A kind of formula of the bone powder fodder containing duck |
Also Published As
Publication number | Publication date |
---|---|
CL2018000925A1 (en) | 2018-08-03 |
EP3361882A1 (en) | 2018-08-22 |
WO2017064092A1 (en) | 2017-04-20 |
CA3001389A1 (en) | 2017-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108289478A (en) | Include the feed addictive for aquatic animal of essential oil and lysozyme | |
AU2016288468B2 (en) | Animal feed compositions and uses thereof | |
US20160128337A1 (en) | Antibacterial compositions and methods of use | |
CN102469808B (en) | Use of natural substances as feed additives for aquatic animals | |
UA125639C2 (en) | Feed additive composition | |
CN103429093A (en) | Feed additive composition | |
KR20170105023A (en) | Beetle powder | |
CN103533843A (en) | Feed additive composition | |
WO2016060934A1 (en) | Bacillus strains with fast germination and antimicrobial activity against clostridium perfringens | |
CN103442587A (en) | Feed additive composition | |
KR20170103842A (en) | Compositions containing chitin and digestible proteins | |
WO2017147130A2 (en) | Direct fed microbial for prevention of shrimp disease | |
KR20150038584A (en) | Use of a xylanase in corn and corn by-products | |
KR100857771B1 (en) | Compositions for addition to feed for fish comprising Bacillus polyfermenticus, Bacillus licheniformis and Saccharomyces serevisiae | |
CN112689461A (en) | Animal feed composition and use thereof | |
BR112021004519A2 (en) | composition of animal feed and its use | |
JP2000004800A (en) | Feed additive and its production | |
RU2460313C2 (en) | Method for production of fodder additive with chondroprotective properties of sea hydrobionts wastes | |
CN1193678C (en) | Ecological feed | |
US20210307361A1 (en) | Compositions and Methods for Feeding Domesticated Animals | |
JP2021153543A (en) | Feed made from waste creamer | |
KR20210057773A (en) | Animal feed composition and use thereof | |
Nouri et al. | Acid hydrolysis of gelatin extracted from cow skin: properties and potential for use as a source of small peptides and free amino acids for broiler chickens | |
JP2016013122A (en) | Feed for aquatic organism and culture method | |
US20240156921A1 (en) | Animal feed composition and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180717 |
|
WD01 | Invention patent application deemed withdrawn after publication |